文献速递血管炎

抗甲状腺药物诱发的ANCA相关性血管炎的特征与结局:一项多中心回顾性病例对照研究

Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该多中心回顾性研究纳入45例抗甲状腺药物(ATD)诱发的ANCA相关性血管炎(AAV)患者,其中24例为显微镜下多血管炎(MPA),并与96例原发性MPA按性别和诊断年份1:4匹配对照。ATD诱发MPA诊断年龄更轻(48 vs 65岁,P<0.001)、皮肤受累更多(54 vs 25%,P=0.007)、肾脏受累更少(38 vs 73%,P=0.02),复发风险更低(校正HR 0.07;95%CI 0.01,0.65,P=0.019)。

要点

  • ATD诱发AAV以MPA为主,MPO-ANCA阳性常见,但MPO与PR3双阳性达33%。
  • 最常见表现为皮肤受累(64%)、关节痛(51%)和肾小球肾炎(20%)。
  • ATD诱发MPA较原发性MPA诊断更年轻、皮肤受累多、肾脏受累少、复发风险低。

核心结论

  • ATD诱发的AAV主要为MPA且多为MPO-ANCA阳性,但MPO与PR3双阳性也较常见。
  • 最常见表现为皮肤和肌肉骨骼表现,ATD诱发MPA较原发性MPA病情更轻且复发风险更低。

研究设计与样本

  • 多中心回顾性研究,纳入45例ATD诱发的AAV患者,其中24例为MPA。
  • 将ATD诱发MPA与原发性MPA按性别和诊断年份1:4匹配,共96例对照。

主要发现

  • 44例(98%)ANCA阳性,其中MPO-ANCA 21例(47%)、PR3-ANCA 6例(13%)、MPO与PR3双阳性15例(33%)。
  • 主要临床表现为皮肤受累64%、关节痛51%、肾小球肾炎20%。
  • 98%的病例停用ATD,其中7例(16%)血管炎缓解;其余患者经糖皮质激素治疗后均缓解,11例(30%)联合利妥昔单抗、4例(11%)联合环磷酰胺。
  • 7例(16%)重新使用ATD,随后均无复发。
  • 与96例匹配的原发性MPA相比,ATD诱发MPA诊断年龄更轻(48 vs 65岁,P<0.001),皮肤受累更常见(54 vs 25%,P=0.007),肾脏受累更少(38 vs 73%,P=0.02),复发风险更低(校正HR 0.07;95%CI 0.01,0.65,P=0.019)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Data on ANCA-associated vasculitis (AAV) induced by anti-thyroid drugs (ATD) are scarce. We aimed to describe the characteristics and outcome of these patients in comparison to primary AAV. METHODS: We performed a retrospective multicentre study including patients with ATD-induced AAV. We focused on ATD-induced microscopic polyangiitis (MPA) and compared them with primary MPA by matching each case with four controls by gender and year of diagnosis. RESULTS: Forty-five patients with ATD-induced AAV of whom 24 MPA were included. ANCA were positive in 44 patients (98%), including myeloperoxidase (MPO)-ANCA in 21 (47%), proteinase 3 (PR3)-ANCA in six (13%), and double positive MPO- and PR3-ANCA in 15 (33%). Main clinical manifestations were skin involvement (64%), arthralgia (51%) and glomerulonephritis (20%). ATD was discontinued in 98% of cases, allowing vasculitis remission in seven (16%). All the remaining patients achieved remission after glucocorticoids, in combination with rituximab in 11 (30%) or cyclophosphamide in four (11%). ATD were reintroduced in seven cases (16%) without any subsequent relapse. Compared with 96 matched primary MPA, ATD-induced MPA were younger at diagnosis (48 vs 65 years, P < 0.001), had more frequent cutaneous involvement (54 vs 25%, P = 0.007), but less frequent kidney (38 vs 73%, P = 0.02), and a lower risk of relapse (adjusted HR 0.07; 95% CI 0.01, 0.65, P = 0.019). CONCLUSION: ATD-induced AAV were mainly MPA with MPO-ANCA, but double MPO- and PR3-ANCA positivity was frequent. The most common manifestations were skin and musculoskeletal manifestations. ATD-induced MPA were less severe and showed a lower risk of relapse than primary MPA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Culerrier J, Nguyen Y, Karadag O, et al. Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study. Rheumatology (Oxford). 2024. PMID: 37354498. doi:10.1093/rheumatology/kead319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。